Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Neutrophil to lymphocyte ratio predicts prognosis in unresectable pancreatic cancer
N. Iwai, Takashi Okuda, Junichi Sakagami, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 88

Showing 1-25 of 88 citing articles:

Lipocalin 2 mediates appetite suppression during pancreatic cancer cachexia
Brennan Olson, Xinxia Zhu, Mason A. Norgard, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 78
Extramedullary hematopoiesis in cancer
Derek A. G. Barisas, Kyunghee Choi
Experimental & Molecular Medicine (2024) Vol. 56, Iss. 3, pp. 549-558
Open Access | Times Cited: 11
Predictors of response to anamorelin in gastrointestinal cancer patients with cachexia: a retrospective study
N. Iwai, Hiroaki Sakai, Kohei Oka, et al.
Supportive Care in Cancer (2023) Vol. 31, Iss. 2
Closed Access | Times Cited: 16
Neutrophil-mediated fibroblast-tumor cell il-6/stat-3 signaling underlies the association between neutrophil-to-lymphocyte ratio dynamics and chemotherapy response in localized pancreatic cancer: A hybrid clinical-preclinical study
Iago De Castro Silva, Anna Bianchi, Nilesh Deshpande, et al.
eLife (2022) Vol. 11
Open Access | Times Cited: 27
Clinical Impact of Nutrition and Inflammation Assessment Tools in Pancreatic Cancer Treatment
TORU AOYAMA, Yukio Maezawa, ITARU HASHIMOTO, et al.
Anticancer Research (2023) Vol. 43, Iss. 9, pp. 3849-3860
Open Access | Times Cited: 15
Combination, Modulation and Interplay of Modern Radiotherapy with the Tumor Microenvironment and Targeted Therapies in Pancreatic Cancer: Which Candidates to Boost Radiotherapy?
Sofian Benkhaled, Cedric Peters, Nicolas Jullian, et al.
Cancers (2023) Vol. 15, Iss. 3, pp. 768-768
Open Access | Times Cited: 13
Bridging nutrition and oncologic care: addressing malnutrition in adjuvant chemotherapy for gastric cancer
Jong Hyuk Yun, Geum Jong Song, Myoung Won Son, et al.
Foregut Surgery (2025) Vol. 5
Closed Access
Neutrophil-to-Lymphocyte Ratio as a Prognostic Biomarker for Long-Term Survival in Older Adults at a Mental Health Care Center: A Historical Cohort Analysis
Piotr Paweł Chmielewski, Bartłomiej Strzelec, Paul Mozdziak, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 7, pp. 2509-2509
Open Access
The Combination of Neutrophil–Lymphocyte Ratio and Platelet–Lymphocyte Ratio with Liquid Biopsy Biomarkers Improves Prognosis Prediction in Metastatic Pancreatic Cancer
Marta Toledano‐Fonseca, María Teresa Cano, Elizabeth Inga, et al.
Cancers (2021) Vol. 13, Iss. 6, pp. 1210-1210
Open Access | Times Cited: 28
The current understanding of the immune landscape relative to radiotherapy across tumor types
Chrysanthi Iliadi, Laurine Verset, Christelle Bouchart, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 11
CD73 controls Myosin II–driven invasion, metastasis, and immunosuppression in amoeboid pancreatic cancer cells
Rémi Samain, Óscar Maiques, Joanne Monger, et al.
Science Advances (2023) Vol. 9, Iss. 42
Open Access | Times Cited: 11
Serum hsa-miR-22-3p, hsa-miR-885-5p, Lipase-to-Amylase Ratio, C-Reactive Protein, CA19-9, and Neutrophil-to-Lymphocyte Ratio as Prognostic Factors in Advanced Pancreatic Ductal Adenocarcinoma
Jakub Wnuk, Dorota Hudy, Joanna Katarzyna Strzelczyk, et al.
Current Issues in Molecular Biology (2025) Vol. 47, Iss. 1, pp. 27-27
Open Access
Prognostic Impacts of Depression and Inflammatory Factors in Pancreatic Cancer Patients
Pisin Chen, Yang-Chen Shen, Cheng‐Feng Lin, et al.
(2025) Vol. 87, Iss. 2, pp. 146-152
Closed Access
Is survival influenced by metastatic site in synchronous metastatic pancreatic adenocarcinoma (PDAC)? A prospective real-world BACAP study
Emily Alouani, Cindy Canivet, Barbara Bournet, et al.
ESMO Gastrointestinal Oncology (2025) Vol. 8, pp. 100144-100144
Closed Access
Inflammatory Markers in Predicting Survival in Pancreatic Cancer: A Systematic Review and Meta-analysis
Rinrada Worapongpaiboon, Noppachai Siranart, Patavee Pajareya, et al.
Pancreatology (2025)
Closed Access
Association between discontinuation of anamorelin and immunotrophic index in patients with cancer-associated cachexia: a single-center retrospective study
Aiko Fukui, Ryosuke Ota, Atsushi Hirata
Research Square (Research Square) (2025)
Closed Access
Ischemic stroke in patients with unresectable pancreatic and gastric cancer
Kohei Oka, N. Iwai, Tomoyuki Ohara, et al.
International Journal of Clinical Oncology (2025)
Closed Access
Prognostic Significance of Peripheral Blood Parameters as Predictor of Neoadjuvant Chemotherapy Response in Breast Cancer
Flaviu Ionuț Faur, Amadeus Dobrescu, Ioana Adelina Clim, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 6, pp. 2541-2541
Open Access
Stroma and lymphocytes identified by deep learning are independent predictors for survival in pancreatic cancer
Xiuxiang Tan, Mika Rosin, Simone Appinger, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Development of a Nomogram Integrating Modified Inflammation-Based Indexes for Predicting Overall Survival in Pancreatic Cancer: A Retrospective Study
Dailei Qin, Kewei Huang, Zehui Yao, et al.
Journal of Inflammation Research (2025) Vol. Volume 18, pp. 4813-4830
Open Access
Effects of Nichi BRITE Beta-Glucans as an onco-nutrition adjuvant in patients undergoing Subtotal stomach-preserving pancreaticoduodenectomy (SSPPD) for pancreatic, bile duct and duodenal malignancies; A clinical study
Akira Tsukada, Isao Miyajima, Satomi Uchiyama, et al.
Nutrition (2025), pp. 112811-112811
Open Access
Prognostic Value of Inflammatory Biomarkers in Patients With Stage I Lung Adenocarcinoma Treated With Surgical Dissection
Yujia Shen, Liqiang Qian, Zhengping Ding, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 24
Prognostic implications of the peripheral platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio in predicting pathologic complete response after neoadjuvant chemotherapy in breast cancer patients
Xiaoyan Jin, Ke Wang, Xuan Shao, et al.
Gland Surgery (2022) Vol. 11, Iss. 6, pp. 1057-1066
Open Access | Times Cited: 18
Inflammatory biomarkers and nanotechnology: new insights in pancreatic cancer early detection
Damiano Caputo, Erica Quagliarini, Alessandro Coppola, et al.
International Journal of Surgery (2023)
Open Access | Times Cited: 10
Platelet-Lymphocyte and Neutrophil-Lymphocyte Ratios Are Prognostic Markers for Pheochromocytomas and Paragangliomas
Xu Zhong, Tingwei Su, Yifan Yang, et al.
The Journal of Clinical Endocrinology & Metabolism (2023) Vol. 108, Iss. 9, pp. 2230-2239
Closed Access | Times Cited: 9
Page 1 - Next Page

Scroll to top